Peter Mitchell

Peter Mitchell is a highly experienced leader in bioprocesses, currently serving as the Chief Operations Officer (COO) and Head of R&D at Cellcraft since 2025. They have previously held notable positions, including Head of Gamma Delta Process Science at Takeda Oncology and Head of Process Sciences at GammaDelta Therapeutics. Peter has a strong background in process development, having worked as Director of Process Development at Xap Therapeutics and Head of Process Development at Advanced Bioprocess Services. They earned a Master of Biology from the University of Bath and a PhD from Southampton University in skeletal tissue engineering.